HEPAR STANNUM II ampoules

Pack size:10 x 1 ml Dosage form:Ampoules

Hepar/Stannum II, liquid dilution for injection. Indications: In accordance with anthroposophical understanding of man and nature. These include: Stimulation of rhythmic balancing and formative processes in inflammatory, resolving, but also degenerative diseases of the liver and their psychological accompanying symptoms, e.g. acute and chronic liver inflammation (hepatitis).

For risks and side effects, read the package insert and ask your doctor or pharmacist.


INSTRUCTIONS FOR USE: INFORMATION FOR THE USER

Hepar/Stannum II, liquid dilution for injection

Composition:
1 ampoule contains: Hepar bovis Gl Dil. D16 0.1 g (HAB, Vs. 41a), Stannum metallicum Dil. D19 aquos. 0.1 g. Other ingredients: Sodium chloride, sodium bicarbonate, water for injections.

Indications:
In accordance with anthroposophical understanding of man and nature. These include: Stimulating rhythmic balancing and regenerative processes in inflammatory and degenerative liver diseases and their associated psychological symptoms, e.g., acute and chronic liver inflammation (hepatitis).

Contraindications:
None known.

Precautions for use and warnings:
There is insufficient documented experience with the use of this medicine in children. It should therefore not be used in children under 12 years of age.

Dosage and method of administration:
Unless otherwise prescribed, inject 1 ml subcutaneously twice a week to once daily.

Duration of use:
Treatment of the disease should be completed after 2 weeks. If no improvement occurs within this period, a doctor should be consulted.

Side effects:
None known.

Contents:
10 x 1 ml.

Pharmaceutical company and manufacturer:
WALA Heilmittel GmbH
Dorfstraße 1,
73087 Bad Boll/Eckwälden.

This package leaflet was last revised in January 2025.

Source: Information from the Wala catalog,
as of: 04/2025

Areas of application: According to the anthroposophical understanding of man and nature. These include: Stimulating rhythmic balancing and formative processes in inflammatory, resolving, and degenerative diseases of the liver, as well as their accompanying psychological symptoms, e.g., acute and chronic liver inflammation (hepatitis).